| Alena M Korbut, PHARMD | |
|
100 S Bliss Ave, Tahlequah, OK 74464-2512 | |
| (918) 458-3147 | |
| Not Available |
| Full Name | Alena M Korbut |
|---|---|
| Gender | Female |
| Speciality | Pharmacist - Pharmacist Clinician (phc)/ Clinical Pharmacy Specialist |
| Location | 100 S Bliss Ave, Tahlequah, Oklahoma |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1144706888 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 1835P0018X | Pharmacist - Pharmacist Clinician (phc)/ Clinical Pharmacy Specialist | 17686 (Oklahoma) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Alena M Korbut, PHARMD 100 S Bliss Ave, Tahlequah, OK 74464-2512 Ph: () - | Alena M Korbut, PHARMD 100 S Bliss Ave, Tahlequah, OK 74464-2512 Ph: (918) 458-3147 |
News Archive
Serono and IVAX Corporation has announced positive results from two clinical trials with a new proprietary oral formulation of cladribine, a potential new treatment for multiple sclerosis (MS). The study results showed that the formulation of oral cladribine which has been developed by Serono and IVAX has met the targets for an orally administered product, with blood levels of cladribine in the expected therapeutic range. Efficacy studies of oral cladribine in MS patients are planned to start late 2004.
GlaxoSmithKline and XenoPort, Inc. announced today that GSK1838262/XP13512 (gabapentin enacarbil) did not demonstrate a statistically significant improvement compared to placebo as a prophylactic treatment for migraine headaches. This phase 2b dose-ranging study evaluated the efficacy, safety and tolerability of GSK1838262 in adults diagnosed with migraine headache (with or without aura) according to the International Headache Society criteria.
Cardima, Inc., a medical device company focused on the treatment of atrial fibrillation and manufacturer of the Cardima Surgical Ablation System, announced today that its common stock will commence trading under the new ticker symbol, "CADMD" following the implementation of a reverse stock split in a 1-for-10 ratio.
iCo Therapeutics, today announced that all nominees listed in the management information circular dated June 1, 2015 were elected as directors at its 2015 Annual Meeting of Shareholders, held earlier today, June 26 2015.
Kindred Healthcare, Inc. today announced that it intends to undertake a refinancing of its existing secured indebtedness. The proposed refinancing would extend the maturity profile of the Company's long-term debt, increase total availability under the Company's secured facilities, improve pricing and provide additional covenant flexibility.
› Verified 4 days ago
Dr. Steven Ray Scott, PHARMD Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 100 S Bliss Ave, Tahlequah, OK 74464 Phone: 918-458-3100 | |
Dr. Ivanne Lynne Chiovoloni, PHARM.D., NCPS, BCPS Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 855 Markoma Circle, Tahlequah, OK 74464 Phone: 918-207-3987 | |
Dr. Gerald Ray Brown Jr., PHARMD Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 100 S Bliss Ave, Tahlequah, OK 74464 Phone: 918-458-3207 | |
Mr. Mark Alan Combrink, PHARMD Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 100 S Bliss Ave, Tahlequah, OK 74464 Phone: 918-458-3105 Fax: 918-458-3508 | |
Roy Mattox, Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 100 S Bliss Ave, Tahlequah, OK 74464 Phone: 918-458-3100 | |
Amanda Rae Bonner, PHARMD Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 100 S Bliss Ave, Tahlequah, OK 74464 Phone: 918-458-3100 | |
Carol Suzanne Saffell, PHARM. D Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 100 S Bliss Ave, Tahlequah, OK 74464 Phone: 918-458-3100 |